Vericel (VCEL) Gross Margin Growth (5y) (2016 - 2026)

Vericel (VCEL) Gross Margin Growth (5y) (2016 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Vericel 2.30 Bn 2.15 Bn 49.27 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 365.00
Dec 31, 2025 431.00
Sep 30, 2025 102.00
Jun 30, 2025 1,698.00
Mar 31, 2025 615.00
Dec 31, 2024 448.00
Sep 30, 2024 250.00
Jun 30, 2024 400.00
Mar 31, 2024 856.00
Dec 31, 2023 217.00
Sep 30, 2023 335.00
Jun 30, 2023 584.00
Mar 31, 2023 718.00
Dec 31, 2022 851.00
Sep 30, 2022 1,623.00
Jun 30, 2022 730.00
Mar 31, 2022 4,136.00
Dec 31, 2021 744.00
Sep 30, 2021 2,827.00
Jun 30, 2021 2,502.00